Are synthetic scaffolds suitable for the development of clinical tissue-engineered tubular organs?

J Biomed Mater Res A. 2014 Jul;102(7):2427-47. doi: 10.1002/jbm.a.34883. Epub 2013 Aug 2.

Abstract

Transplantation of tissues and organs is currently the only available treatment for patients with end-stage diseases. However, its feasibility is limited by the chronic shortage of suitable donors, the need for life-long immunosuppression, and by socioeconomical and religious concerns. Recently, tissue engineering has garnered interest as a means to generate cell-seeded three-dimensional scaffolds that could replace diseased organs without requiring immunosuppression. Using a regenerative approach, scaffolds made by synthetic, nonimmunogenic, and biocompatible materials have been developed and successfully clinically implanted. This strategy, based on a viable and ready-to-use bioengineered scaffold, able to promote novel tissue formation, favoring cell adhesion and proliferation, could become a reliable alternative to allotransplatation in the next future. In this article, tissue-engineered synthetic substitutes for tubular organs (such as trachea, esophagus, bile ducts, and bowel) are reviewed, including a discussion on their morphological and functional properties.

Keywords: in vitro and in vivo evaluation; organs and tissues; synthetic biomaterials; tissue engineering.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Retracted Publication

MeSH terms

  • Humans
  • Tissue Engineering*
  • Tissue Scaffolds*
  • Transplantation